It's up to the scientific
community to maintain and enforce international codes of ethics regarding clinical
research on
gene therapy techniques, the authors say.
Still, BioViva has pressed ahead with telomerase
gene therapy, and factions within the
research community are also aiming for the same outcome of human tests, though through more conventional channels.